首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Myocardial metabolism of 123I-BMIPP under low-dose dobutamine infusion: implications for clinical SPECT imaging of ischemic heart disease.
【24h】

Myocardial metabolism of 123I-BMIPP under low-dose dobutamine infusion: implications for clinical SPECT imaging of ischemic heart disease.

机译:低剂量多巴酚丁胺输注下的123I-BMIPP心肌代谢:对缺血性心脏病的临床SPECT成像的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: 123I-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (123I-BMIPP) is a fatty acid analog for single-photon emission computed tomography (SPECT) imaging that is mainly stored in the triglyceride pool. Low-dose dobutamine infusion has been reported to improve BMIPP uptake in the stunned myocardium, but the mechanism underlying this effect remains unclear. The purpose of this study was therefore to investigate the myocardial metabolism of 123I-BMIPP in the stunned myocardium under low-dose dobutamine infusion, and to elucidate the mechanism by which dobutamine improves BMIPP uptake. METHODS: Using open-chest dogs, stunned myocardium was induced by occlusion of the left anterior descending artery (LAD) for 30 min, with subsequent reperfusion (ischemia group, n=6). After direct injection of BMIPP into the LAD, myocardial extraction and retention were examined and metabolites evaluated (using high-performance liquid chromatography) during dobutamine infusion. The results in the ischemia group were compared with findings obtained in a control group under dobutamine infusion (n=6). RESULTS: Dobutamine infusion significantly increased both the rapid extraction (within 30 s) of BMIPP into the myocardium (control vs ischemia group: 48+/-19% vs 66+/-14%, p<0.05) and its subsequent retention (73+/-13% vs 85+/-8%, p<0.05). The metabolites from the myocardium consisted of back diffusion of nonmetabolized BMIPP, the alpha-oxidation metabolite, intermediate metabolites, and the full-oxidation metabolite. Among these metabolites, the full-oxidation metabolite decreased significantly (from 34.0+/-20.0% to 15.8+/-9.3%, p<0.05) in the stunned regions, though back diffusion of nonmetabolized BMIPP increased (from 51.3+/-21.9% to 71.3+/-10.1%, p<0.05). CONCLUSION: These results indicate that increased uptake of BMIPP in stunned myocardium is mainly due to decreased beta-oxidation in tissue and increased shunt retention of BMIPP in the triglyceride pool, and thereby provide further insight into the pathophysiology of stunned myocardium.
机译:用途:123I-(对碘苯基)-3-(R,S)-甲基十五碳二烯酸(123I-BMIPP)是一种用于单光子发射计算机断层扫描(SPECT)成像的脂肪酸类似物,主要存储在甘油三酸酯池中。据报道,低剂量多巴酚丁胺输注可改善昏迷心肌的BMIPP吸收,但尚不清楚这种作用的机制。因此,本研究的目的是调查低剂量多巴酚丁胺输注下昏迷的心肌中123I-BMIPP的心肌代谢,并阐明多巴酚丁胺改善BMIPP摄取的机制。方法:使用开胸的狗,左前降支(LAD)闭塞30分钟,然后再灌注(缺血组,n = 6),诱发震惊的心肌。将BMIPP直接注射入LAD后,在多巴酚丁胺输注期间检查心肌的提取和保留情况,并评估代谢物(使用高效液相色谱法)。将缺血组的结果与多巴酚丁胺输注(n = 6)对照组的结果进行比较。结果:多巴酚丁胺输注显着增加了BMIPP在心肌中的快速提取(在30 s内)(对照组vs缺血组:48 +/- 19%vs 66 +/- 14%,p <0.05)及其随后的保留(73) +/- 13%与85 +/- 8%,p <0.05)。来自心肌的代谢物包括未代谢的BMIPP的反向扩散,α-氧化代谢物,中间代谢物和全氧化代谢物。在这些代谢产物中,虽然未代谢的BMIPP的向后扩散增加(从51.3 +/- 21.9),但在氧化区,全氧化代谢产物显着降低(从34.0 +/- 20.0%降至15.8 +/- 9.3%,p <0.05)。 %至71.3 +/- 10.1%,p <0.05)。结论:这些结果表明,昏迷的心肌中BMIPP的摄取增加主要是由于组织中的β氧化减少以及甘油三酸酯池中的BMIPP的分流保留增加,从而进一步了解了昏迷的心肌的病理生理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号